Drug Shortage Report for JANUMET XR

Last updated on 2019-02-27 History
Report ID 74192
Drug Identification Number 02416808
Brand name JANUMET XR
Common or Proper name sitagliptin and metformin hydrochloride modified-release tablets
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 1000MG 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 30 Tab
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-03-04
Actual start date
Estimated end date 2019-02-27
Actual end date 2019-02-27
Shortage status Avoided shortage
Updated date 2019-02-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-02-27 French Compare
v6 2019-02-27 English Compare
v5 2019-02-19 French Compare
v4 2019-02-19 English Compare
v3 2019-02-01 French Compare
v2 2019-02-01 French Compare
v1 2019-02-01 English Compare

Showing 1 to 7 of 7